{
    "clinical_study": {
        "@rank": "114407", 
        "arm_group": [
            {
                "arm_group_label": "Placebo - Grade 1", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "ATX-101 - Grade 1", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo - Grade 4", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "ATX-101 - Grade 4", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The objectives of this study are to explore the safety and efficacy of subcutaneous\n      injections of ATX-101 relative to placebo, in the submental area."
        }, 
        "brief_title": "Safety Study of ATX-101 in Subjects With Varying Chin Sizes", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Submental Fat", 
            "Safety", 
            "Efficacy", 
            "Healthy Volunteers"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female subjects, 18 to 65 years old\n\n          -  Stable Body weight\n\n          -  BMI of \u226440.0 kg/m2\n\n          -  Acceptable volume of submental fat graded by clinician\n\n          -  Dissatisfaction with the submental area expressed by the subject\n\n          -  Signed informed consent form (ICF)\n\n        Exclusion Criteria:\n\n          -  No prior intervention for SMF (eg, liposuction, surgery, or lipolytic agents)\n\n          -  Absence of clinically significant health problems\n\n          -  History of any intervention to treat SMF (eg, liposuction, surgery, or lipolytic\n             agents)\n\n          -  History of trauma associated with the chin or neck areas that in the judgment of the\n             investigator may affect evaluation of safety or efficacy of treatment\n\n          -  Body mass index \u226440 kg/m2"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02035267", 
            "org_study_id": "ATX-101-13-27"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "ATX-101 - Grade 1", 
                    "ATX-101 - Grade 4"
                ], 
                "intervention_name": "ATX-101", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Placebo - Grade 1", 
                    "Placebo - Grade 4"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 17, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Steven Yoelin, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Rick Glogau, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Hollywood", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90069"
                    }, 
                    "name": "Derek Jones, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Steve Fagien, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coral Gables", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33146"
                    }, 
                    "name": "Frederic Brandt, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glenn Dale", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20769"
                    }, 
                    "name": "Valerie Callender, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chestnut Hills", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02467"
                    }, 
                    "name": "Jeff Dover, MD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Dee Anna Glaser, MD"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4", 
        "overall_contact": {
            "email": "adavis@clinicalsiteservices.com", 
            "last_name": "Amy Davis", 
            "phone": "1-877-284-1213"
        }, 
        "overall_official": {
            "affiliation": "Sponsor GmbH", 
            "last_name": "Frederick Beddingfield, III, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Safety assessments on incidents of all Adverse Events", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Safety assessments on severity of all Adverse Events", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Safety assessments with Laboratory Measurements", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Safety Assessments on duration of all Adverse Events", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02035267"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Efficacy assessments using a clinician rating scale", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Efficacy assessments using patient reported scales", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Efficacy assessments using a submental skin laxity grade scale", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Efficacy assessment on submental fat using calipers", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Efficacy assessments using standardized photography", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }, 
            {
                "measure": "Efficacy assessments using FACE-Q scales", 
                "safety_issue": "No", 
                "time_frame": "up to 32 weeks"
            }
        ], 
        "source": "Kythera Biopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kythera Biopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}